Graduate students, postdocs, and other trainees who receive a stipend often assume, incorrectly, that the stipend itself is a reportable financial conflict of interest (FCOI). In almost every case it is not. The distinction that matters is not the word “stipend” but where the money comes from: ordinary compensation paid by your own institution is generally excluded from significant-financial-interest (SFI) reporting, while payments from a source outside your institution — a company, a foreign university, a foundation with its own funding relationship to your research topic — often are reportable. This guide walks through why, using the federal regulatory definition that most US research institutions build their disclosure policies around, and flags the situations where a stipend-like payment does need to be disclosed.
The short answer
If your stipend, salary, or fellowship payment is issued by the institution where you are enrolled or employed — even if the underlying money originated as a federal training grant, an NIH Kirschstein-NRSA award, or general university funds — it is not, by itself, a Significant Financial Interest under the federal Public Health Service (PHS) conflict-of-interest regulation, 42 CFR Part 50, Subpart F. If a stipend, honorarium, consulting fee, or in-kind benefit comes from outside your institution — a pharmaceutical or biotech company, a foreign government or university, a nonprofit unaffiliated with your training program, or an outside co-author’s employer — it can trigger a disclosure obligation, particularly once it exceeds the regulatory dollar threshold or involves equity.
What the regulation actually says
42 CFR 50.603 defines a Significant Financial Interest and, critically, builds in an explicit institutional-salary exclusion. The regulation excludes from SFI reporting:
“salary, royalties, or other remuneration paid by the Institution to the Investigator if the Investigator is currently employed or otherwise appointed by the Institution, including intellectual property rights assigned to the Institution and agreements to share in royalties related to such rights.”
In plain terms: your institution paying you for work you do at that institution is the normal employment relationship the regulation is designed to work around, not the kind of external financial entanglement it exists to catch. A predoctoral or postdoctoral stipend funded through an NIH T32 institutional training grant, an F31/F32 individual fellowship routed through your institution’s payroll or student accounts system, or a university-funded research assistantship all fall inside this exclusion, because the payment is administered and paid by the institution itself, even though the ultimate funding source is federal.
For payments that are not excluded, 42 CFR 50.603 sets the reporting bar at aggregated remuneration (over the prior twelve months) plus equity exceeding $5,000 for a publicly traded entity, or remuneration exceeding $5,000 — or any equity interest at all, regardless of value — for a non-publicly-traded entity. It also reaches intellectual-property/royalty income and certain sponsored or reimbursed travel. See CASRAI’s Significant Financial Interest definition for the full breakdown of these thresholds and exclusions.
Who this actually applies to
42 CFR Part 50 Subpart F’s disclosure duty attaches to an “Investigator” — defined broadly as the project director/principal investigator and any other person responsible for the design, conduct, or reporting of PHS-funded research, not only the PI listed on the Notice of Award. Whether a given trainee counts as an Investigator under this definition, and therefore has an independent federal disclosure obligation, depends on their actual role: a graduate student or postdoc who is named as senior/key personnel, who designs experiments, analyzes data, or is an author responsible for reported findings on a PHS-funded project can meet this definition even without holding the PI title. A student who is simply supported on a training grant stipend without that level of research responsibility may not independently meet it — though many institutions extend their own COI disclosure policy more broadly than the federal floor requires, so your institution’s actual policy, not just the federal regulation, is the controlling document. Check with your institution’s research integrity or COI office, not just this general framework, before assuming you are or are not covered.
When a trainee’s payment does need to be disclosed
The institutional-salary exclusion only covers money paid by your own institution. A number of common trainee and early-career situations sit outside it and should be evaluated for disclosure:
- Industry-sponsored fellowships or stipend top-ups. If a company supplements your institutional stipend directly, or funds a fellowship administered by a foundation with its own reporting relationship to that company, that payment is coming from outside your institution and is evaluated under the ordinary SFI thresholds.
- Consulting, honoraria, or speaking fees paid to you personally by an outside entity — including one connected to your dissertation or postdoctoral research topic — even if modest in amount.
- Equity or stock options in a company related to your research, including a startup a faculty mentor has founded. Under 42 CFR 50.603, any equity interest in a non-publicly-traded entity is reportable regardless of dollar value — there is no minimum threshold the way there is for cash remuneration. CASRAI’s guide on faculty conflict of interest in startups covers the mentor-side version of this same issue.
- A co-author’s outside financial relationships that are relevant to a paper you are writing together. Journal-level conflict-of-interest disclosure (see CASRAI’s guide to conflict-of-interest disclosure in scholarly publication) is a separate obligation from institutional FCOI, and it asks about every author’s relevant financial relationships, not just the corresponding author’s or PI’s.
- Travel, lodging, or subsistence paid by an outside sponsor to attend a conference or site visit connected to your research, above the regulation’s reporting threshold.
- A stipend or salary paid by a second institution — for example, a joint-appointment, visiting-scholar, or dual-degree arrangement where a foreign university or a non-home institution pays you directly for work related to your research. This does not fall inside your primary institution’s own-salary exclusion.
Stipend, fellowship, or salary: does the label matter?
No. The regulation does not turn on what the payment is called — “stipend,” “salary,” “fellowship award,” “training allowance” are all administrative labels, not regulatory categories. What matters is (1) who is paying and (2) whether that payer is the institution where you are currently employed or appointed. An NRSA predoctoral stipend administered by your university’s grants office is institutional-source money even though NIH ultimately funds it; a stipend paid directly to you by an outside foundation with no institutional intermediary is a closer case and should be raised with your COI office. See CASRAI’s NRSA stipend levels reference for how these federal training stipends are structured and administered.
Practical steps for trainees
- Identify the payer, not just the payment. Trace every stipend, honorarium, or in-kind benefit you receive back to its immediate source. If it is issued by your own institution’s payroll, student accounts, or grants office, it is very likely excluded.
- Read your institution’s actual COI disclosure policy rather than relying on the federal floor alone — many institutions require broader disclosure from trainees named as key personnel or authors than 42 CFR Part 50 strictly requires. CASRAI’s conflict-of-interest disclosure form guide covers what a typical institutional disclosure form asks for.
- Disclose outside relationships even when you are unsure. COI offices routinely field disclosures that turn out not to meet the SFI threshold; over-disclosure is a minor administrative event, while a missed disclosure that is later discovered can become a compliance finding.
- Separately track journal-level disclosure obligations when you co-author a manuscript. A financial relationship that does not rise to an institutional SFI can still need to be disclosed to a journal under ICMJE-based conflict-of-interest policies, which use their own, typically broader, disclosure criteria.
- Re-disclose annually and within 30 days of a new interest if you are formally designated an Investigator under your institution’s FCOI policy — 42 CFR 50.604 sets this cadence for PHS-funded investigators generally.
Frequently asked questions
Does my NIH T32 or F31/F32 stipend count as a conflict of interest?
No. A training-grant or individual-fellowship stipend administered through your institution is paid by the institution, which is exactly what 42 CFR 50.603’s institutional-salary exclusion covers, even though the underlying funds originate from NIH.
I’m a graduate student, not the PI — do I even need to file an FCOI disclosure?
It depends on your actual role and your institution’s specific policy. The federal “Investigator” definition covers anyone responsible for the design, conduct, or reporting of PHS-funded research, which can include a graduate student or postdoc with substantive research responsibility, not only the named PI. Many institutions also apply their own COI policy more broadly than the federal minimum. Confirm with your institution’s research integrity or COI office.
My co-author on a paper has a financial relationship with a company relevant to our topic — does that affect me?
It affects the paper’s journal-level conflict-of-interest disclosure, which typically requires every listed author to disclose their own relevant financial relationships, not just the corresponding author’s. It does not, by itself, create an institutional FCOI obligation for you unless you separately hold a reportable financial interest.
What if a company pays me directly on top of my institutional stipend?
That outside payment is not covered by the institutional-salary exclusion because it does not come from your institution. Evaluate it against the standard SFI thresholds ($5,000 aggregated remuneration, or any equity in a non-publicly-traded entity) and disclose it through your institution’s COI process.
Does equity in a mentor’s startup count even if I’m just a trainee in the lab, not a founder?
Yes, if you personally hold the equity. 42 CFR 50.603 reaches any equity interest in a non-publicly-traded entity regardless of dollar value or your role at the company — holding even a small number of shares or options is reportable if the entity is related to your institutional research responsibilities.
Related CASRAI resources
- Significant Financial Interest — the full 42 CFR 50.603 definition and thresholds
- Conflict of Interest — general definition
- Conflict of Interest Disclosure
- Conflict of Interest Disclosure Form — what institutional forms typically ask
- Types of Conflict of Interest
- Conflict of Interest Disclosure in Scholarly Publication — the parallel journal-level obligation
- Faculty Conflict of Interest in Startups — the mentor/faculty-founder side of the equity issue above
- NRSA Stipend Levels
- NIH Conflict of Interest Policy
This guide explains the general federal framework under 42 CFR Part 50, Subpart F, and is not a substitute for your own institution’s conflict-of-interest policy, which may impose broader disclosure requirements. Confirm your specific obligations with your institution’s research integrity, sponsored programs, or COI office.
